  | Tychon, C., Poleur, M., & Servais, L. (14 March 2025). Walking speed during daily living, a systematic review [Poster presentation]. BAoP Congress, Mons, Belgium. |
 | Servais, L., Strijbos, P., Poleur, M., Mirea, A., Butoianu, N., Sansone, V. A., Vuillerot, C., Schara-Schmidt, U., Scoto, M., Seferian, A. M., Previtali, S. C., Tulinius, M., Nascimento, A., Furlong, P., Singh, T., Dreghici, R. D., Goemans, N., Mercuri, E., Straub, V., ... Eggenspieler, D. (29 November 2024). Evidentiary basis of the first regulatory qualification of a digital primary efficacy endpoint. Scientific Reports, 14 (1), 29681. doi:10.1038/s41598-024-80177-9  Peer Reviewed verified by ORBi |
 | Poleur, M., Parinello, G., Vrščaj, E., Kumhera, M., Bisson, C., Aragon-Gawińska, K., Anghelescu, C., Daron, A., Szabo, L., Leanca, M., Mirea, A., Kodsy, S., Saleh, A., Osredkar, D., Haberlova, J., Potulska-Chromik, A., Butoianu, N., Eggenspieler, D., Strijbos, P., & Servais, L. (October 2024). 400P Longitudinal evaluation of ambulatory function with ankle wearable technology in ambulant DMD. Neuromuscular Disorders, 43, 104441.128. doi:10.1016/j.nmd.2024.07.137 Peer Reviewed verified by ORBi |
 | Smeets, N., Gheldof, A., Dequeker, B., Poleur, M., Maldonado Slootjes, S., Van Parijs, V., Deconinck, N., Dontaine, P., Alonso-Jimenez, A., De Bleecker, J., De Ridder, W., Herdewyn, S., Paquay, S., Vanlander, A., De Waele, L., Peirens, G., Beysen, D., Claeys, K. G., Dubuisson, N., ... Régal, L. (September 2024). Congenital Myasthenic Syndromes in Belgium: Genetic and Clinical Characterization of Pediatric and Adult Patients. Pediatric Neurology, 158, 57 - 65. doi:10.1016/j.pediatrneurol.2024.06.002 Peer Reviewed verified by ORBi |
 | Poleur, M., Willekens, B., Degos, B., Ricard, D., Van Pesch, V., Tricot, A., Medard, L., Li, H., Lommers, E., Michaud, M., Strijbos, P., Overell, J., Cluzeau, C., Eggenspieler, D., & Servais, L. (09 April 2024). Reliability and External Validity of Digital Passive Gait Tracking in MS (P6-6.008) [Poster presentation]. American Academy of Neurology. doi:10.1212/wnl.0000000000206099 Peer reviewed |
 | Poleur, M., Nemr, A., Bancel, L., Parinello, G., Cluzeau, C., Bechichi, Y., DELSTANCHE, S., & Servais, L. (09 April 2024). Digital Outcome Measure Assessing the Motor Function of Patients with Amyotrophic Lateral Sclerosis (P5-11.011) [Poster presentation]. American Academy of Neurology. doi:10.1212/wnl.0000000000205650 Peer reviewed |
 | Poleur, M., Lievens, I., & WANG, F.-C. (April 2024). Un spectre en pleine expansion [Paper presentation]. JNLF, Paris, France. |
  | Mouraux, C., Dangouloff, T., Poleur, M., Mackels, L., Vanden Brande, L., Daron, A., Servais, L., Maertens de Noordhout, A., & DELSTANCHE, S. (2024). Epidemiological study and diagnostic approach analysis of Neuromuscular population of Neuromuscular Reference Center of Liege, Belgium [Poster presentation]. BeSHG annual symposium 2024, Belgium. Peer reviewed |
 | Poleur, M., Tricot, A., Medard, L., Gevenois, N., Lozeve, D., Maertens De Noordhout, A., Bouquiaux, O., Lommers, E., Michaud, M., Annoussamy, M., & Servais, L. (2023). Analytical validation of innovative magneto-inertial outcomes: a controlled environment study. Multiple Sclerosis Journal. Peer Reviewed verified by ORBi |
 | Servais, L., Eggenspieler, D., Poleur, M., Grelet, M., Muntoni, F., Strijbos, P., & Annoussamy, M. (October 2023). First regulatory qualification of a digital primary endpoint to measure treatment efficacy in DMD. Nature Medicine, 29 (10), 2391 - 2392. doi:10.1038/s41591-023-02459-5 Peer Reviewed verified by ORBi |
 | Poleur, M., Markati, T., & Servais, L. (02 August 2023). The use of digital outcome measures in clinical trials in rare neurological diseases: a systematic literature review. Orphanet Journal of Rare Diseases, 18 (1), 224. doi:10.1186/s13023-023-02813-3 Peer Reviewed verified by ORBi |
 | Bancel, L., Tricot, A., Guérin, A., Eggenspieler, D., Lilien, C., Poleur, M., & Servais, L. (2023). Digital outcome captures longitudinal degradation of upper-limb function in non-ambulant patients affected by neuromuscular disorders. Neuromuscular Disorders, 33, 80. doi:10.1016/j.nmd.2023.07.079 Peer Reviewed verified by ORBi |
 | Rogers, M., Motola, S., Eggenspieler, D., Poleur, M., Parinello, G., Lozeve, D., Danon, A., Szabo, L., Aragon-Gawińska, K., Potulska-Chromik, A., Butoianu, N., Anghelescu, C., Mirea, Osredkar, D., Vrščaj, E., Golli, T., Haberlova, J., Kodsy, S., Salah, A., ... Servais, L. (2023). Analysis of the natural evolution of SV95C in ambulant patients with Duchenne muscular dystrophy. Neuromuscular Disorders, 33, 81. doi:10.1016/j.nmd.2023.07.080 Peer Reviewed verified by ORBi |
 | Vrščaj, E., Jilkova, M., Aragon-Gawinska, K., Anghelescu, C., Axente, M., Poleur, M., Daron, A., Szabo, L., Mirea, A., Kodsy, S., Saleh, A., Osredkar, D., Haberlova, J., Potulska-Chromik, A., Butoianu, N., Strijbos, P., Eggenspieler, D., & Servais, L. (2023). Longitudinal multi-centric study to assess the digital outcomes issued from wearable magneto-inertial devices in ambulant DMD. Neuromuscular Disorders, 33, 163. doi:10.1016/j.nmd.2023.07.393 Peer Reviewed verified by ORBi |
 | Rogers, M., Motola, S., Eggenspieler, D., Poleur, M., Parinello, G., Lozeve, D., Danon, A., Szabo, L., Aragon-Gawińska, K., Potulska-Chromik, A., Butoianu, N., Anghelescu, C., Mirea, Osredkar, D., Vrščaj, E., Haberlova, J., Kodsy, S., Salah, A., Strijbos, P., & Servais, L. (2023). Factors affecting the measurement variability of SV95C in ambulant patients with Duchenne muscular dystrophy. Neuromuscular Disorders, 33, 82. doi:10.1016/j.nmd.2023.07.085 Peer Reviewed verified by ORBi |
 | Poleur, M., Maertens De Noordhout, A., Lievens, I., & Delstanche, S. (2023). Overview of Patients With Chronic Inflammatory Demyelinating Polyneuropathy of the Neuromuscular Reference Center of Liège. Journal of Neuromuscular Diseases. Peer Reviewed verified by ORBi |
 | Poleur, M., Hustinx, M., LIEVENS, I., & De Noordhout, A. M. (April 2022). Neuropathie motrice multifocale avec blocs de conduction persistants : une entité obsolète ? [Poster presentation]. Journées de Neurologie de Langue Française. doi:10.1016/j.neurol.2022.02.249 Peer reviewed |
 | Annoussamy, M., Eggenspieler, D., Seferian, A., Mercuri, E., Straub, V., Muntoni, F., Scoto, M., Poleur, M., Daron, A., Butoianu, N., Mirea, A., Goemans, N., Previtali, S., Tulinius, M., Nascimento, A., Heydemann, P., Panzara, M., Singh, T., Strijbos, P., & Servais, L. (2022). Application for primary endpoint qualification of the 95th centile of stride velocity (SV95C) in Duchenne muscular dystrophy. Neuromuscular Disorders. doi:10.1016/j.nmd.2022.07.099 Peer Reviewed verified by ORBi |
 | Poleur, M., Annoussamy, M., Clavel, L., Buscemi, L., DELSTANCHE, S., Eggenspieler, D., Maertens De Noordhout, A., Bouquiaux, O., Lievens, I., & Servais, L. (2022). Wearable inertial sensors for longitudinal follow-up of patients with amyotrophic lateral sclerosis. Nervno-Myšečnye Bolezni. Peer Reviewed verified by ORBi |
| Hustinx, M., Poleur, M., Daron, A., Maertens De Noordhout, A., Servais, L., & Delstanche, S. (2022). Overlap Between Hereditary Sensory- Motor Neuropathy (HSMN) and Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP). Journal of Neuromuscular Diseases. Peer Reviewed verified by ORBi |
 | Poleur, M., Ulinici, A., DARON, A., Schneider, O., Farra, F. D., Demonceau, M., Annoussamy, M., Vissière, D., Eggenspieler, D., & Servais, L. (October 2021). Actimyo®: Normative data in a non-controlled environment. Neuromuscular Disorders, 31, 86-S87. doi:10.1016/j.nmd.2021.07.149 Peer Reviewed verified by ORBi |
 | Poleur, M., Annoussamy, M., Eggenspieler, D., DELSTANCHE, S., DARON, A., & Servais, L. (October 2021). Longitudinal follow-up of adult patients with spinal muscular atrophy undergoing nusinersen treatment using an innovative magneto-inertial device. Neuromuscular Disorders, 31, 130. doi:10.1016/j.nmd.2021.07.290 Peer Reviewed verified by ORBi |
 | Poleur, M., Ulinici, A., DARON, A., Schneider, O., Dal Farra, F., Demonceau, M., Annoussamy, M., Vissière, D., Eggenspieler, D., & Servais, L. (2021). Normative data on spontaneous stride velocity, stride length, and walking activity in a non-controlled environment. Orphanet Journal of Rare Diseases. doi:10.1186/s13023-021-01956-5 Peer Reviewed verified by ORBi |
